1.ICP-MS determination of ten elemental impurities in meglumine
Junmin LAI ; Zhifang LI ; Minshan ZENG ; Juan ZHANG ; Xiaohong YAN
Drug Standards of China 2024;25(5):452-457
Objective:To establish an ICP-MS method for the determination of 10 elemental impurities in meglu-mine(APIs).Methods:The samples were processed by closed high-pressure microwave digestion,and the con-tents of the Class 1 elemental impurities arsenic(As),cadmium(Cd),mercury(Hg)and lead(Pb),the Class 2 A elemental impurities cobalt(Co),nickel(Ni)and vanadium(V),and the Class 3 elemental impurities lithium(Li),antimony(Sb)and copper(Cu)were detected by ICP-MS with total quantification.Results:The linear correlation coefficients(r)of each elemental impurity were greater than 0.997.The recoveries of the spiked samples ranged from 93.6%to 116.8%with RSD values of the recoveries lower than 7.4%.RSD values of the precision were lower than 5.4%.The content of nickel in 11 batches of the samples was lower than the permissible daily exposure(PDE)of the impurities of the elements of category 2A in the elemental guideline of ICH Q3D(R2)for oral use but higher than that of PDE of the impurities of category 2A for injection.Conclusion:The method is sensitive and precise enough to accurately determine the levels of Class 1,2A and 3 elemental impurities in meglumine.Nine batches of meglumine were found to have a high risk of nickel residue.
2.Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Meng YUAN ; Qian WU ; Mingyang ZHANG ; Minshan LAI ; Wenbo CHEN ; Jianfeng YANG ; Li JIANG ; Ji CAO
Journal of Zhejiang University. Science. B 2023;24(3):207-220
A series of chemotherapeutic drugs that induce DNA damage, such as cisplatin (DDP), are standard clinical treatments for ovarian cancer, testicular cancer, and other diseases that lack effective targeted drug therapy. Drug resistance is one of the main factors limiting their application. Sensitizers can overcome the drug resistance of tumor cells, thereby enhancing the antitumor activity of chemotherapeutic drugs. In this study, we aimed to identify marketable drugs that could be potential chemotherapy sensitizers and explore the underlying mechanisms. We found that the alcohol withdrawal drug disulfiram (DSF) could significantly enhance the antitumor activity of DDP. JC-1 staining, propidium iodide (PI) staining, and western blotting confirmed that the combination of DSF and DDP could enhance the apoptosis of tumor cells. Subsequent RNA sequencing combined with Gene Set Enrichment Analysis (GSEA) pathway enrichment analysis and cell biology studies such as immunofluorescence suggested an underlying mechanism: DSF makes cells more vulnerable to DNA damage by inhibiting the Fanconi anemia (FA) repair pathway, exerting a sensitizing effect to DNA damaging agents including platinum chemotherapy drugs. Thus, our study illustrated the potential mechanism of action of DSF in enhancing the antitumor effect of DDP. This might provide an effective and safe solution for combating DDP resistance in clinical treatment.
Female
;
Male
;
Humans
;
Cisplatin/pharmacology*
;
Disulfiram/pharmacology*
;
Testicular Neoplasms/drug therapy*
;
Fanconi Anemia/drug therapy*
;
Alcoholism/drug therapy*
;
Drug Resistance, Neoplasm
;
Cell Line, Tumor
;
Substance Withdrawal Syndrome/drug therapy*
;
Apoptosis
;
Antineoplastic Agents/therapeutic use*
;
Cell Proliferation